Global Naltrexone Buprenorphine Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Naltrexone Buprenorphine Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 10.2% CAGR, to an estimated market size of $7.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global naltrexone and buprenorphine market includes pharmaceutical products used in Medication-Assisted Treatment (MAT) for substance use disorders, primarily Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD). The scope covers various formulations including oral, sublingual, long-acting injectables, and implants, while excluding non-pharmacological therapies and traditional abstinence-only programs.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Naltrexone Buprenorphine Market in the period 2025-30:
- The removal of the X-waiver via the MATE Act has significantly expanded the potential prescriber base for buprenorphine in the United States.
- There is a rapid clinical shift toward long-acting injectable (LAI) formulations to improve patient adherence and reduce the risk of medication diversion.
- The permanent integration of telehealth platforms into MAT programs is increasing treatment retention rates and expanding access to rural populations.
- Escalating global prevalence of synthetic opioids, such as fentanyl, is driving urgent demand for high-efficacy pharmacological interventions.
- Increased government funding and legislative efforts, such as the 21st Century Cures Act, are improving insurance reimbursement and parity for addiction treatment.
- Persistent social stigma and a lack of specialized provider training remain the primary barriers to widespread market penetration.
- Innovation in abuse-deterrent formulations and subdermal implants is expected to define the next generation of recovery maintenance therapy.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Buprenorphine-based Products
- Naltrexone-based Products